Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1036
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanda, Amulya Kumar-
dc.contributor.authorSaneja, Ankit-
dc.contributor.authorKumar, Robin-
dc.contributor.authorArora, Divya-
dc.contributor.authorKumar, Sandeep-
dc.contributor.authorJaglan, Sundeep-
dc.date.accessioned2020-07-10T07:36:43Z-
dc.date.available2020-07-10T07:36:43Z-
dc.date.issued2018-05-
dc.identifier.urihttp://hdl.handle.net/123456789/1036-
dc.description.abstractIn recent years, research has focused on the development of smart nanocarriers that can respond to specific stimuli. Among the various stimuli-responsive platforms for cancer therapy, near-infrared (NIR) light (700–1000 nm)-responsive nanocarriers have gained considerable interest because of their deeper tissue penetration capacity, precisely controlled drug release, and minimal damage towards normal tissues. In this review, we outline various therapeutic applications of NIR-responsive nanocarriers in drug delivery, photothermal therapy (PTT), photodynamic therapy (PDT), and bioimaging. We also highlight recent trends towards NIR-responsive combinatorial therapy and multistimuli-responsive nanocarriers for improving therapeutic outcomes.en_US
dc.publisherElsevier B.Ven_US
dc.titleRecent advances in near-infrared light-responsive nanocarriers for cancer therapyen_US
dc.journalDrug Descov Todayen_US
dc.volumeno23en_US
dc.issueno5en_US
dc.pages1115-1125en_US
Appears in Collections:Product Development Cell Unit- II, Publications

Files in This Item:
File Description SizeFormat 
1-s2.0-S1359644617304270-main.pdfResearch Article1.9 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.